InsiderPulseNo transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2026-02-11 | Jonathan Jackson(D-IL01) | house | Sale | $1,001 - $15,000 |
| 2025-12-10 | Jonathan Jackson(D-IL01) | house | Purchase | $15,001 - $50,000 |
| 2025-09-03 | Jonathan Jackson(D-IL01) | house | Purchase | $1,001 - $15,000 |
| 2025-08-04 | Lisa McClain(R-MI09) | house | Sale | $1,001 - $15,000 |
| 2025-06-11 | Lisa McClain(R-MI09) | house | Purchase | $1,001 - $15,000 |
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net operating revenues | $21.31B+3.1% | $20.68B+0.5% | $20.56B+7.2% | $19.17B-1.6% | $19.48B |
| Equity in earnings of unconsolidated affiliates | $264.0M+1.5% | $260.0M+14.0% | $228.0M+5.6% | $216.0M-0.9% | $218.0M |
| Salaries, wages and benefits | $8.71B-1.1% | $8.80B-3.8% | $9.15B+3.4% | $8.84B-0.4% | $8.88B |
| Supplies | $3.78B+3.6% | $3.65B+1.6% | $3.59B+9.7% | $3.27B-1.7% | $3.33B |
| Other operating expenses, net | $4.52B+0.7% | $4.49B-0.5% | $4.51B+12.9% | $4.00B-4.9% | $4.21B |
| Depreciation and amortization | $863.0M+5.5% | $818.0M-6.0% | $870.0M+3.4% | $841.0M-1.6% | $855.0M |
| Impairment and restructuring charges, and acquisition-related costs | $130.0M+27.5% | $102.0M-25.5% | $137.0M-39.4% | $226.0M+165.9% | $85.0M |
| Litigation and investigation costs | $64.0M+82.9% | $35.0M-25.5% | $47.0M-32.9% | $70.0M-39.7% | $116.0M |
| Net losses (gains) on sales, consolidation and deconsolidation of facilities | $1.0M+100.0% | -$2.92B-12578.3% | -$23.0M | — | — |
| Operating income | $3.51B-41.1% | $5.96B+137.3% | $2.51B+7.6% | $2.33B-18.7% | $2.87B |
| Interest expense | -$821.0M+0.6% | -$826.0M+8.3% | -$901.0M-1.2% | -$890.0M+3.6% | -$923.0M |
| Other non-operating income, net | $117.0M-7.1% | $126.0M+563.2% | $19.0M+72.7% | $11.0M-21.4% | $14.0M |
| Loss from early extinguishment of debt | -$4.0M+50.0% | -$8.0M+27.3% | -$11.0M+89.9% | -$109.0M-47.3% | -$74.0M |
| Income before income taxes | $2.80B-46.6% | $5.25B+224.6% | $1.62B+20.2% | $1.34B | — |
| Income tax expense | -$433.0M+63.4% | -$1.18B-286.9% | -$306.0M+11.0% | -$344.0M+16.3% | -$411.0M |
| Net income | $2.37B-41.8% | $4.06B+210.0% | $1.31B+31.0% | $1.00B-32.2% | $1.48B |
| Less: Net income available to noncontrolling interests | $960.0M+11.1% | $864.0M+23.4% | $700.0M+18.6% | $590.0M+5.0% | $562.0M |
| Net income available to Tenet Healthcare Corporation common shareholders | $1.41B-56.0% | $3.20B+423.7% | $611.0M+48.7% | $411.0M-55.0% | $914.0M |
| Basic earnings per share (in dollars per share) | $15.6M-52.7% | $33.0M+449.4% | $6.0M+56.5% | $3.8M | — |
| Diluted earnings per share (in dollars per share) | $15.5M-52.6% | $32.7M+472.7% | $5.7M+50.7% | $3.8M | — |
| Basic (in shares) | $90.15B-7.0% | $96.90B-4.7% | $101.64B-4.9% | $106.93B+0.1% | $106.83B |
| Diluted (in shares) | $90.83B-7.2% | $97.88B-6.6% | $104.80B-5.2% | $110.52B+1.8% | $108.57B |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Tenet Healthcare Corporation Q1 2026 Earnings Call Summary
Tenet outlines $1.6B-$1.83B 2026 adjusted free cash flow after NCI while reaffirming full-year guidance
Tenet Healthcare Corporation (THC) Q1 2026 Earnings Call Transcript
Tenet (THC) Q1 2026 Earnings Call Transcript